logo
logo

Microcaps Closes CHF 5 Million Seed Financing Round Co-led by Helvetica Capital and Zürcher Kantonalbank

Jan 26, 2021•over 4 years ago

Round Type

seed

Zurich

Description

Microcaps AG, a developer of formulation, processes and equipment to generate precision microcapsules, announced today that it has closed a CHF 5 million seed financing round co-led by Helvetica Capital and Zürcher Kantonalbank. The ETH Zurich Foundation, the Lichtsteiner Foundation and a group of Swiss entrepreneurs participated significantly in the financing. Microcaps has co-developed many proprietary formulations with industrial clients and will use the proceeds of the financing to launch its first product, a customized microcapsule production unit and associated consumables for sample batch sizes, and grow its team, which will be based at new corporate facilities in Zurich.

Company Information

Company

Microcaps

Location

Zurich, Zurich, Switzerland

About

Microcaps’s unique and patented technology allows the development and manufacturing of microcapsules at an unmatched precision and efficiency. This provides customers with tailored microencapsulation solutions that enable precise release of contents. Offering individual benefits for different applications; controlled release, targeted delivery, and shear-free encapsulation, the technology has its largest impact potential in the fields of pharmaceuticals, nutrition and cosmetics. In 2018, co-founders Alessandro Ofner and Michael Hagander received the pioneer fellowship award from the ETH Zurich Foundation, which allowed them to start Microcaps. In 2020, Microcaps won the ZKB Pionierpreis Technopark, one of the most prestigious startup prizes in Switzerland, sponsored by Zürcher Kantonalbank (ZKB). Further information can be found at www.microcaps.ch.

Related People